Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sihuan Pharmaceutical Hldgs (460 HK)
Watchlist
46
Analysis
Health Care
•
China
Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
27 Jun 2024 12:04
Voluntary Announcement-Calcium Dobesilate Capsules Developed By Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa
Attachment
Exchange Announcement •
26 Jun 2024 12:00
Voluntary Announcement-Ticagrelor Orodispersible Tablet Obtained Drug Registration Approval From Nmpa
Attachment
Exchange Announcement •
24 Jun 2024 18:30
Next Day Disclosure Return
Attachment
Exchange Announcement •
19 Jun 2024 19:16
Voluntary Announcement - Share Purchase Pursuant To The Share Award Scheme
Attachment
Exchange Announcement •
18 Jun 2024 17:24
Voluntary Announcement Share Purchase Pursuant To The Share Award Scheme
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x